• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,741.82 238.22
( 0.31%)
Global Indices
Nasdaq
52,357.11 -589.04
(-1.11%)
Dow Jones
7,503.65 -21.20
(-0.28%)
Hang Seng
67,966.49 1,147.44
(1.72%)
Nikkei 225
10,472.08 -16.96
(-0.16%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
285.6722314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
22.92
15943.23
EPS(TTM)
Face Value()
Div & Yield %
35.39
2
1.48
 

Sammaan Capital reports consolidated net loss of Rs 8101.41 crore in the March 2026 quarter
May 21,2026
Net loss of Sammaan Capital reported to Rs 8101.41 crore in the quarter ended March 2026 as against net profit of Rs 324.04 crore during the previous quarter ended March 2025. Sales declined 35.58% to Rs 1357.66 crore in the quarter ended March 2026 as against Rs 2107.43 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 7144.56 crore in the year ended March 2026 as against net loss of Rs 1807.46 crore during the previous year ended March 2025. Sales declined 5.30% to Rs 8166.16 crore in the year ended March 2026 as against Rs 8623.33 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1357.662107.43 -36 8166.168623.33 -5
OPM %-139.7671.41 -41.6028.28 -
PBDT-3572.41479.69 PL -2196.82-2292.55 4
PBT-3597.45454.99 PL -2285.25-2375.57 4
NP-8101.41324.04 PL -7144.56-1807.46 -295